Latest Administration News

InhaleRx has secured FDA alignment and ethics approvals to progress clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, with patient dosing set to begin soon.

DGR Global Limited’s Q3 2025 report reveals ongoing project development, strategic equity holdings, and complex legal proceedings shaping its resource company creation model.

Paterson Resources has completed a $1.7 million capital raise, positioning itself to launch an 8,500-meter drilling campaign at its Grace Gold-Copper Project in Western Australia’s Paterson Province. This program aims to upgrade the project’s resource classification and support a mining lease application.

BOA Resources is progressing drill plans for key lithium and nickel tenements in Western Australia, though heritage survey delays have pushed timelines. The company is also streamlining its portfolio to focus on high-potential assets.

InteliCare Holdings reported a $834,000 operating cash outflow for Q3 2025 but bolstered its balance sheet with a $1.8 million capital raise, positioning itself to sustain operations over the coming quarters.

Mustera Property Group has advanced its Verse on McCabe development with design finalised and a strong sales campaign, securing over $10 million in contracts post-quarter. Meanwhile, Forbes Residences continues to deliver solid sales and the company benefits from refinancing that reduces financing costs.

Thrive Tribe Technologies reported a $451,000 net operating cash outflow in Q1 FY26 but bolstered its cash reserves to $589,000 through over $1 million in equity placements. The company progressed its Thrive Tribe Home Base initiative and expanded its digital business units while managing a limited cash runway.

DataWorks Group has extended its Canadian iGaming Ontario contract with new call centre capabilities, driving revenue growth and operational efficiencies that position the company for positive cash flow in FY26.

MEC Resources has advanced its investment in Advent Energy and issued shares to directors, while its PEP 11 Joint Venture faces ongoing legal scrutiny ahead of a Federal Court hearing.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

Janus Electric reported a modest revenue increase in Q1 FY26 despite supply chain setbacks and remains suspended from ASX pending audit completion. A $5 million strategic investment from EVUNI Pte Ltd promises to accelerate growth, particularly in sub-Saharan Africa.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.